@article{KonradJacobRappetal.2016,
  author    = {Konrad, Marcel and Jacob, Louis and Rapp, Michael A. and Kostev, Karel},
  title     = {Depression risk in patients with coronary heart disease in Germany},
  series = {World Journal of Cardiology},
  volume    = {8},
  journal   = {World Journal of Cardiology},
  publisher = {Baishideng Publishing Group},
  address   = {Pleasanton},
  issn      = {1949-8462},
  doi       = {10.4330/wjc.v8.i9.547},
  pages     = {547 -- 552},
  year      = {2016},
  abstract  = {AIM To determine the prevalence of depression and its risk factors among patients with coronary heart disease (CHD) treated in German primary care practices. METHODS Longitudinal data from nationwide general practices in Germany (n = 1072) were analyzed. Individuals initially diagnosed with CHD (2009-2013) were identified, and 59992 patients were included and matched (1: 1) to 59992 controls. The primary outcome measure was an initial diagnosis of depression within five years after the index date among patients with and without CHD. Cox proportional hazards models were used to adjust for confounders. RESULTS Mean age was equal to 68.0 years (SD = 11.3). A total of 55.9\% of patients were men. After a five-year follow-up, 21.8\% of the CHD group and 14.2\% of the control group were diagnosed with depression (P < 0.001). In the multivariate regression model, CHD was a strong risk factor for developing depression (HR = 1.54, 95\% CI: 1.49-1.59, P < 0.001). Prior depressive episodes, dementia, and eight other chronic conditions were associated with a higher risk of developing depression. Interestingly, older patients and women were also more likely to be diagnosed with depression compared with younger patients and men, respectively. CONCLUSION The risk of depression is significantly increased among patients with CHD compared with patients without CHD treated in primary care practices in Germany. CHD patients should be routinely screened for depression to ensure improved treatment and management.},
  language  = {en}
}
@article{BookerBohlkenRappetal.2016,
  author    = {Booker, Anke and Bohlken, Jens and Rapp, Michael A. and Kostev, Karel},
  title     = {Persistence with antidepressant drugs in patients with dementia: a retrospective database analysis},
  series = {International journal of clinical pharmacology and therapeutics},
  volume    = {54},
  journal   = {International journal of clinical pharmacology and therapeutics},
  publisher = {Dustri-Verlag Dr. Karl Feistle},
  address   = {Deisenhofen-M{\~A}¼nchen},
  issn      = {0946-1965},
  doi       = {10.5414/CP202572},
  pages     = {323 -- 329},
  year      = {2016},
  abstract  = {Background: The aims of the present study are to determine what proportion of patients with dementia receives antidepressants, how long the treatment is administered, and what factors increase the risk of discontinuation. Methods: The study was based on Disease Analyzer database and included 1,203 general practitioners (GP) and 209 neurologists/psychiatrists (NP). 12,281 patients with a diagnosis of dementia and an initial prescription of an antidepressant drug between January 2004 and December 2013 were included. The main outcome measure was antidepressant discontinuation rates within 6 months of the index date. Results: After 6 months of follow-up, 52.7\% of dementia patients treated with antidepressants had stopped medication intake. There was a significantly decreased risk for treatment discontinuation for patients using selective serotonin reuptake inhibitors (SSRRIs) or serotonin and norepinephrine reuptake inhibitors (SSNRIs) compared to tricyclic antidepressants. There was a significantly increased risk of treatment discontinuation for older patients and patients treated in NP practice. Comorbidity of diabetes or history of stroke was associated with a decreased risk of treatment discontinuation. Conclusion: The study results show insufficient persistence in antidepressant treatment in dementia patients in a real world setting. The improvement must be achieved to ensure the treatment recommended in the guidelines.},
  language  = {en}
}
@article{BookerJacobRappetal.2016,
  author    = {Booker, Anke and Jacob, Louis E. C. and Rapp, Michael A. and Bohlken, Jens and Kostev, Karel},
  title     = {Risk factors for dementia diagnosis in German primary care practices},
  series = {International psychogeriatrics},
  volume    = {28},
  journal   = {International psychogeriatrics},
  publisher = {Cambridge Univ. Press},
  address   = {New York},
  issn      = {1041-6102},
  doi       = {10.1017/S1041610215002082},
  pages     = {1059 -- 1065},
  year      = {2016},
  abstract  = {Background: Dementia is a psychiatric condition the development of which is associated with numerous aspects of life. Our aim was to estimate dementia risk factors in German primary care patients. Methods: The case-control study included primary care patients (70-90 years) with first diagnosis of dementia (all-cause) during the index period (01/2010-12/2014) (Disease Analyzer, Germany), and controls without dementia matched (1:1) to cases on the basis of age, sex, type of health insurance, and physician. Practice visit records were used to verify that there had been 10 years of continuous follow-up prior to the index date. Multivariate logistic regression models were fitted with dementia as a dependent variable and the potential predictors. Conclusions: Risk factors for dementia found in this study are consistent with the literature. Nevertheless, the associations between statin, PPI and antihypertensive drug use, and decreased risk of dementia need further investigations.},
  language  = {en}
}
@article{ReppertPudellKocetal.2016,
  author    = {Reppert, Alexander von and Pudell, Jan-Etienne and Koc, A. and Reinhardt, M. and Leitenberger, Wolfram and Dumesnil, K. and Zamponi, Flavio and Bargheer, Matias},
  title     = {Persistent nonequilibrium dynamics of the thermal energies in the spin and phonon systems of an antiferromagnet},
  series = {Structural dynamics},
  volume    = {3},
  journal   = {Structural dynamics},
  publisher = {American Institute of Physics},
  address   = {Melville},
  issn      = {2329-7778},
  doi       = {10.1063/1.4961253},
  pages     = {11},
  year      = {2016},
  abstract  = {We present a temperature and fluence dependent Ultrafast X-Ray Diffraction study of a laser-heated antiferromagnetic dysprosium thin film. The loss of antiferromagnetic order is evidenced by a pronounced lattice contraction. We devise a method to determine the energy flow between the phonon and spin system from calibrated Bragg peak positions in thermal equilibrium. Reestablishing the magnetic order is much slower than the cooling of the lattice, especially around the Neel temperature. Despite the pronounced magnetostriction, the transfer of energy from the spin system to the phonons in Dy is slow after the spin-order is lost. (C) 2016 Author(s).},
  language  = {en}
}
@misc{StroehleRapp2016,
  author    = {Stroehle, Andreas and Rapp, Michael A.},
  title     = {Prevention of Cognitive Decline: A Physical Exercise Perspective on Brain Health in the Long Run},
  series = {Journal of the American Medical Directors Association},
  volume    = {17},
  journal   = {Journal of the American Medical Directors Association},
  publisher = {Elsevier},
  address   = {New York},
  issn      = {1525-8610},
  doi       = {10.1016/j.jamda.2016.02.030},
  pages     = {461 -- 462},
  year      = {2016},
  language  = {en}
}
@article{SeboldSchadNebeetal.2016,
  author    = {Sebold, Miriam and Schad, Daniel and Nebe, Stephan and Garbusow, Maria and Juenger, Elisabeth and Kroemer, Nils B. and Kathmann, Norbert and Zimmermann, Ulrich S. and Smolka, Michael N. and Rapp, Michael A. and Heinz, Andreas and Huys, Quentin J. M.},
  title     = {Pavlovian-to-Instrumental Transfer Effects Rely Less on Model-based Reinforcement Learning},
  series = {Journal of cognitive neuroscience},
  volume    = {28},
  journal   = {Journal of cognitive neuroscience},
  publisher = {MIT Press},
  address   = {Cambridge},
  issn      = {0898-929X},
  doi       = {10.1162/jocn_a_00945},
  pages     = {985 -- 995},
  year      = {2016},
  abstract  = {Behavioral choice can be characterized along two axes. One axis distinguishes reflexive, model-free systems that slowly accumulate values through experience and a model-based system that uses knowledge to reason prospectively. The second axis distinguishes Pavlovian valuation of stimuli from instrumental valuation of actions or stimulus-action pairs. This results in four values and many possible interactions between them, with important consequences for accounts of individual variation. We here explored whether individual variation along one axis was related to individual variation along the other. Specifically, we asked whether individuals' balance between model-based and model-free learning was related to their tendency to show Pavlovian interferences with instrumental decisions. In two independent samples with a total of 243 participants, Pavlovian-instrumental transfer effects were negatively correlated with the strength of model-based reasoning in a two-step task. This suggests a potential common underlying substrate predisposing individuals to both have strong Pavlovian interference and be less model-based and provides a framework within which to interpret the observation of both effects in addiction.},
  language  = {en}
}
@phdthesis{Booker2016,
  author    = {Booker, Anke},
  title     = {Datenbankbasierte epidemiologische Untersuchung {\"u}ber die Versorgung demenzerkrankter Patienten},
  school      = {Universit{\"a}t Potsdam},
  year      = {2016},
  abstract  = {Hintergrund: Demenz wird von der Weltgesundheitsorganisation als ein in der Regel chronisch oder progressiv verlaufendes Syndrom definiert, das von einer Vielzahl von Hirnerkrankungen verursacht wird, welche das Ged{\"a}chtnis, das Denkverm{\"o}gen, das Verhalten und die F{\"a}higkeit, allt{\"a}gliche T{\"a}tigkeiten auszuf{\"u}hren, beeinflussen. Weltweit leiden 47,5 Millionen Menschen unter Demenz und diese Zahl wird sich voraussichtlich bis zum Jahr 2050 verdreifachen. In den vorliegenden Studien wurden zum Einem die Faktoren, welche mit dem Risiko einhergehen eine Demenz zu entwickeln, analysiert. Zum Anderen wurde die Persistenz der medikament{\"o}sen Behandlung von depressiven Zust{\"a}nden mit Antidepressiva sowie die Persistenz der medikament{\"o}sen Behandlung von Verhaltensst{\"o}rungen, therapiert mit Antipsychotika, bei Demenzpatienten untersucht. Durchf{\"u}hrung: Alle drei Studien basieren auf den Daten der IMS Disease Analyzer-Datenbank. Die Daten der Disease Analyzer-Datenbank werden {\"u}ber standardisierte Schnittstellen direkt monatlich aus dem Praxiscomputer generiert. Die Daten werden vor der {\"U}bertragung verschl{\"u}sselt und entsprechen in Umfang und Detaillierungsgrad der Patientenakte. Risikofaktoren f{\"u}r eine Demenzdiagnose Methode: Insgesamt wurden in die Studie 11.956 Patienten mit einer Erstdiagnose (Indexdatum) einer Demenz (ICD 10: F01, F03, G30) zwischen Januar 2010 und Dezember 2014 eingeschlossen. 11.956 Kontrollpatienten (ohne Demenz) wurden den Patienten nach Alter, Geschlecht, Art der Krankenversicherung und Arzt zugeordnet. In beiden F{\"a}llen wurden die Praxisaufzeichnungen dazu verwendet, sicherzustellen, dass die Patienten vor dem Indexdatum jeweils 10 Jahre kontinuierlich beobachtet worden waren. Insgesamt wurden 23.912 Personen betrachtet. Mehrere Erkrankungen, die m{\"o}glicherweise mit Demenz assoziiert sind, wurden anhand von allgemein{\"a}rztlichen Diagnosen bestimmt (ICD-10-Codes): Diabetes (E10-E14), Hypertonie (I10), Adipositas (E66), Hyperlipid{\"a}mie (E78), Schlaganfall (einschließlich transitorische isch{\"a}mische Attacke, TIA) (I63, I64, G45), Parkinson-Krankheit (G20, G21), intrakranielle Verletzung (S06), koronare Herzkrankheit (I20-I25), leichte kognitive Beeintr{\"a}chtigung (F06) und psychische und Verhaltensst{\"o}rungen durch Alkohol (F10). Das Vorhandensein mehrerer Medikamente, wie z. B. Statine, Protonenpumpenhemmer und Antihypertensiva (einschließlich Diuretika, Beta-Blocker, Calciumkanalblocker, ACE-Hemmer und Angiotensin-II), wurde ebenfalls bemessen. Ergebnisse: Das Durchschnittsalter f{\"u}r die 11.956 Demenzpatienten und die 11.956 der Kontrollkohorte war 80,4 (SD 5,3) Jahre. 39,0\% der waren m{\"a}nnlich. In dem multivariaten Regressionsmodell, wurden folgende Variablen mit einem erh{\"o}hten Risiko von Demenz in einem signifikanten Einfluß assoziiert: milde kognitive Beeintr{\"a}chtigung (MCI) (OR: 2,12), psychische und Verhaltensst{\"o}rungen durch Alkohol (1,96), Parkinson-Krankheit (PD) (1,89), Schlaganfall (1,68), intrakranielle Verletzung (1,30), Diabetes (1,17), Fettstoffwechselst{\"o}rung (1,07), koronare Herzkrankheit (1,06). Der Einsatz von Antihypertensiva (0,96), Statinen (OR: 0,94) und Protonen-Pumpen-Inhibitoren (PPI) (0,93) wurden mit einem verringerten Risiko der Entwicklung von Demenz. Schlussfolgerung: Die gefundenen Risikofaktoren f{\"u}r Demenz stehen in Einklang mit der Literatur. Nichtsdestotrotz bed{\"u}rfen die Zusammenh{\"a}nge zwischen der Verwendung von Statinen, PPI und Antihypertensiva und einem verringerten Demenzrisiko weiterer Untersuchungen. Persistenz der Behandlung mit Antidepressiva bei Patienten mit Demenz Methode: Patienten wurden ausgew{\"a}hlt, wenn bei ihnen im Zeitraum zwischen Januar 2004 und Dezember 2013 eine Demenzdiagnose (ICD 10: F01, F03, G30) und eine erste Verordnung eines trizyklischen Antidepressivums oder selektiven Serotonin- Wiederaufnahmehemmers (SSRI) oder Serotonin-Noradrenalin-Wiederaufnahmehemmers (SSNRI) vorlagen. Ausgew{\"a}hlte Patienten wurden {\"u}ber einen Zeitraum von bis zu zwei Jahre nach dem Indexdatum beobachtet. Das letzte Nachbeobachtungsdatum eines Patienten war der 31. Dezember 2014. Insgesamt standen 12.281 Patienten f{\"u}r die Persistenzanalyse zur Verf{\"u}gung. Der Hauptzielparameter war die Abbruchrate der Antidepressivabehandlung innerhalb von sechs Monaten nach dem Indexdatum. Behandlungsabbruch wurde definiert als ein Zeitraum von 90 Tagen ohne diese Therapie. Als demographische Daten wurden Alter, Art der Krankenversicherung (privat oder gesetzlich), Art der Praxis (Neurologe oder Allgemeinmediziner) und Praxisregion (Ost- oder Westdeutschland) erhoben. Die folgenden Demenzdiagnosen wurden ber{\"u}cksichtigt: Alzheimer-Krankheit (G30), vaskul{\"a}re Demenz (F01) und nicht n{\"a}her bezeichnete Demenz (F03). Dar{\"u}ber hinaus wurde der Charlson-Komorbidit{\"a}ts-Index als allgemeiner Marker f{\"u}r Komorbidit{\"a}t verwendet. Dar{\"u}ber hinaus wurden die folgenden Diagnosen als Komorbidit{\"a}ten in die Studie aufgenommen: Depression (ICD 10: F32-33), Delir (F05), Typ-2-Diabetes mellitus (E11, E14), Hypertonie (I10), koronare Herzkrankheit (I24, I25), Schlaganfall (I63, I64), Myokardinfarkt (I21-23) und Herzinsuffizienz (I50). Ergebnisse: Nach sechs Monaten Nachbeobachtung hatten 52,7 \% (von 12,281 Demenzpatienten) der mit Antidepressiva behandelten Demenzpatienten die Medikamenteneinnahme abgebrochen. Die multivariaten Regressionsanalysen zeigten ein signifikant geringeres Risiko f{\"u}r einen Behandlungsabbruch bei mit SSRRI oder SSNRI behandelten Patienten verglichen mit Patienten, die trizyklische Antidepressiva einnahmen. Es zeigte sich ein signifikant geringeres Risiko eines Behandlungsabbruchs bei j{\"u}ngeren Patienten. Schlussfolgerung: Die Ergebnisse zeigen eine unzureichende Persistenz mit Antipsychotika bei Demenzpatienten unter Alltagsbedingungen. Es muss eine Verbesserung erreicht werden, um die in den Richtlinien empfohlene Behandlung sicherzustellen. Persistenz der Behandlung mit Antipsychotika bei Patienten mit Demenz Methode: Diese Studie umfasste Patienten im Alter ab 60 Jahren mit Demenz beliebigen Ursprungs, die zwischen Januar 2009 und Dezember 2013 (Indexdatum) zum ersten Mal Antipsychotikaverordnungen (ATC: N05A) von deutschen Psychiatern erhielten. Der Nachbeobachtungszeitraum endete im Oktober 2015. Die Demenz wurde auf Grundlage der ICD-10-Codes f{\"u}r vaskul{\"a}re Demenz (F01), nicht n{\"a}her bezeichnete Demenz (F03) und Alzheimer-Krankheit (G30) bewertet. Der Hauptzielparameter war die Behandlungspersistenzrate {\"u}ber einen Zeitraum von mehr als 6 Monaten nach dem Indexdatum. Die Persistenz wurde als Therapiezeit ohne Absetzen der Behandlung, definiert als mindestens 180 Tage ohne Antipsychotikatherapie, gesch{\"a}tzt. Alle Patienten wurden f{\"u}r eine Dauer von bis zu zwei Jahren ab ihrem Indexdatum beobachtet. Gleichzeitig auftretende Erkrankungen wurden anhand von Diagnosen (ICD-10-Codes) von Depression (F32, F33), Parkinson-Krankheit (G20), psychischer St{\"o}rungen aufgrund bekannter physiologischer Erkrankungen (F06) und Pers{\"o}nlichkeits- und Verhaltensst{\"o}rungen aufgrund physiologischer Erkrankungen (F07) bestimmt. Als demographische Daten wurden Alter, Geschlecht und Art der Krankenversicherung (privat/gesetzlich) erhoben. Ergebnisse: 12,979 Demenzpatienten mit einem Durchschnittsalter von 82 Jahre (52.1\% leben in Pflegeheimen) wurden in diese Studie analysiert. Nach zwei Jahren Nachbeobachtung hatten 54,8 \%, 57,2 \%, 61,1 \% bzw. 65,4 \% der Patienten zwischen 60-69, 70-79, 80-89 bzw. 90-99 Jahren Antipsychotikaverordnungen erhalten (p<0,001). 82,6 \% der in Pflegeheimen lebenden Patienten und 76,2 \% der Patienten in h{\"a}uslicher Pflege setzten ihre Behandlung ebenfalls l{\"a}nger als 6 Monate fort; nach zwei Jahren lag der Anteil bei 63,9 \% (in Pflegeheimen) bzw. 55,0 \% (in h{\"a}uslicher Pflege) (p<0,001). Schlussfolgerung: Die Studie zeigt, dass der Anteil der mit Antipsychotika behandelten Demenzpatienten sehr hoch ist. Weitere Studien, einschließlich qualitativer Untersuchungen, sind n{\"o}tig, um die Gr{\"u}nde f{\"u}r dieses Verschreibungsverhalten zu verstehen und zu erkl{\"a}ren.},
  language  = {de}
}
@article{KonradBohlkenRappetal.2016,
  author    = {Konrad, Marcel and Bohlken, Jens and Rapp, Michael A. and Kostev, Karel},
  title     = {Depression risk in patients with heart failure in primary care practices in Germany},
  series = {International psychogeriatrics},
  volume    = {28},
  journal   = {International psychogeriatrics},
  publisher = {Cambridge Univ. Press},
  address   = {New York},
  issn      = {1041-6102},
  doi       = {10.1017/S1041610216000867},
  pages     = {1889 -- 1894},
  year      = {2016},
  abstract  = {Background: The goal of this study was to estimate the prevalence of and risk factors for diagnosed depression in heart failure (HF) patients in German primary care practices. Methods: This study was a retrospective database analysis in Germany utilizing the Disease Analyzer (R) Database (IMS Health, Germany). The study population included 132,994 patients between 40 and 90 years of age from 1,072 primary care practices. The observation period was between 2004 and 2013. Follow-up lasted up to five years and ended in April 2015. A total of 66,497 HF patients were selected after applying exclusion criteria. The same number of 66,497 controls were chosen and were matched (1:1) to HF patients on the basis of age, sex, health insurance, depression diagnosis in the past, and follow-up duration after index date. Results: HF was a strong risk factor for diagnosed depression (p < 0.0001). A total of 10.5\% of HF patients and 6.3\% of matched controls developed depression after one year of follow-up (p < 0.001). Depression was documented in 28.9\% of the HF group and 18.2\% of the control group after the five-year follow-up (p < 0.001). Cancer, dementia, osteoporosis, stroke, and osteoarthritis were associated with a higher risk of developing depression. Male gender and private health insurance were associated with lower risk of depression. Conclusions: The risk of diagnosed depression is significantly increased in patients with HF compared to patients without HF in primary care practices in Germany.},
  language  = {en}
}
@article{HaeuslerSanchezGellertetal.2016,
  author    = {H{\"a}usler, Andreas and S{\´a}nchez, Alba and Gellert, Paul and Deeken, Friederike and Rapp, Michael A. and Nordheim, Johanna},
  title     = {Perceived stress and quality of life in dementia patients and their caregiving spouses: does dyadic coping matter?},
  series = {International psychogeriatrics},
  volume    = {28},
  journal   = {International psychogeriatrics},
  publisher = {Cambridge Univ. Press},
  address   = {New York},
  issn      = {1041-6102},
  doi       = {10.1017/S1041610216001046},
  pages     = {1857 -- 1866},
  year      = {2016},
  abstract  = {Background: Given the well-established association between perceived stress and quality of life (QoL) in dementia patients and their partners, our goal was to identify whether relationship quality and dyadic coping would operate as mediators between perceived stress and QoL. Results: We found negative correlations between stress and QoL in both partners (QoL-AD: r = -0.62; p < 0.001; WHO-QOL Overall: r = -0.27; p = 0.02). Spousal caregivers had a significantly lower DCI total score than dementia patients (p < 0.001). Dyadic coping was a significant mediator of the relationship between stress and QoL in spousal caregivers (z = 0.28; p = 0.02), but not in dementia patients. Likewise, relationship quality significantly mediated the relationship between stress and QoL in caregivers only (z = -2.41; p = 0.02). Conclusions: This study identified dyadic coping as a mediator on the relationship between stress and QoL in (caregiving) partners of dementia patients. In patients, however, we found a direct negative effect of stress on QoL. The findings suggest the importance of stress reducing and dyadic interventions for dementia patients and their partners, respectively.},
  language  = {en}
}
@article{BookersJacobBohlkenetal.2016,
  author    = {Bookers, Anke and Jacob, Louis and Bohlken, Jens and Rapp, Michael A. and Kostev, Karel},
  title     = {Persistence with antipsychotics in dementia patients in Germany},
  series = {International journal of clinical pharmacology and therapeutics},
  volume    = {54},
  journal   = {International journal of clinical pharmacology and therapeutics},
  publisher = {Dustri-Verlag Dr. Karl Feistle},
  address   = {Deisenhofen-M{\~A}¼nchen},
  issn      = {0946-1965},
  doi       = {10.5414/CP202631},
  pages     = {835 -- 840},
  year      = {2016},
  abstract  = {Background/Aims: To analyze the duration of treatment with antipsychotics in German dementia patients. Methods: This study included patients aged 60 years and over with dementia who received a first-time antipsychotic prescription by psychiatrists between 2009 and 2013. The main outcome measure was the treatment rate for more than 6 months following the index date. Results: A total of 12,979 patients with dementia (mean age 82 years, 52.1\% living in nursing homes) were included. After 2 years of follow-up, 54.8\%, 57.2\%, 61.1\%, and 65.4\% of patients aged 60 - 69, 70 - 79, 80 - 89, and 90 - 99 years, respectively, received antipsychotic prescriptions. 63.9\% of subjects living in nursing homes and 55.0\% of subjects living at home also continued their treatment (p-value < 0.001). Conclusion: The percentage of dementia patients treated with anti psychotics is very high.},
  language  = {en}
}
@misc{HeinzKlugeRapp2016,
  author    = {Heinz, A. and Kluge, U. and Rapp, Michael A.},
  title     = {Heritability of living in deprived neighbourhoods},
  series = {Translational Psychiatry},
  volume    = {6},
  journal   = {Translational Psychiatry},
  publisher = {Nature Publ. Group},
  address   = {New York},
  issn      = {2158-3188},
  doi       = {10.1038/tp.2016.215},
  pages     = {1},
  year      = {2016},
  language  = {en}
}
@article{ReppertPuddellKocetal.2016,
  author    = {Reppert, Alexander von and Puddell, J. and Koc, A. and Reinhardt, M. and Leitenberger, Wolfram and Dumesnil, K. and Zamponi, Flavio and Bargheer, Matias},
  title     = {Persistent nonequilibrium dynamics of the thermal energies in the spin and phonon systems of an antiferromagnet},
  series = {Structural dynamics},
  volume    = {3},
  journal   = {Structural dynamics},
  publisher = {AIP Publishing LLC},
  address   = {Melville, NY},
  issn      = {2329-7778},
  doi       = {10.1063/1.4961253},
  year      = {2016},
  abstract  = {We present a temperature and fluence dependent Ultrafast X-Ray Diffraction study of a laser-heated antiferromagnetic dysprosium thin film. The loss of antiferromagnetic order is evidenced by a pronounced lattice contraction. We devise a method to determine the energy flow between the phonon and spin system from calibrated Bragg peak positions in thermal equilibrium. Reestablishing the magnetic order is much slower than the cooling of the lattice, especially around the N{\´e}el temperature. Despite the pronounced magnetostriction, the transfer of energy from the spin system to the phonons in Dy is slow after the spin-order is lost.},
  language  = {en}
}
@misc{HeinzBeckRapp2016,
  author    = {Heinz, Andreas and Beck, Anne and Rapp, Michael A.},
  title     = {Alcohol as an Environmental Mortality Hazard},
  series = {JAMA psychiatry},
  volume    = {73},
  journal   = {JAMA psychiatry},
  publisher = {American Veterinary Medical Association},
  address   = {Chicago},
  issn      = {2168-622X},
  doi       = {10.1001/jamapsychiatry.2016.0399},
  pages     = {549 -- 550},
  year      = {2016},
  language  = {en}
}
@article{SanderKocKwamenetal.2016,
  author    = {Sander, Mathias and Koc, A. and Kwamen, C. T. and Michaels, H. and Reppert, Alexander von and Pudell, Jan-Etienne and Zamponi, Flavio and Bargheer, Matias and Sellmann, J. and Schwarzkopf, J. and Gaal, P.},
  title     = {Characterization of an ultrafast Bragg-Switch for shortening hard x-ray pulses},
  series = {Journal of applied physics},
  volume    = {120},
  journal   = {Journal of applied physics},
  publisher = {American Institute of Physics},
  address   = {Melville},
  issn      = {0021-8979},
  doi       = {10.1063/1.4967835},
  pages     = {7},
  year      = {2016},
  abstract  = {We present a nanostructured device that functions as photoacoustic hard x-ray switch. The device is triggered by femtosecond laser pulses and allows for temporal gating of hard x-rays on picosecond (ps) timescales. It may be used for pulse picking or even pulse shortening in 3rd generation synchrotron sources. Previous approaches mainly suffered from insufficient switching contrasts due to excitation-induced thermal distortions. We present a new approach where thermal distortions are spatially separated from the functional switching layers in the structure. Our measurements yield a switching contrast of 14, which is sufficient for efficient hard x-ray pulse shortening. The optimized structure also allows for utilizing the switch at high repetition rates of up to 208 kHz. Published by AIP Publishing.},
  language  = {en}
}
@misc{HeinzVossLawrieetal.2016,
  author    = {Heinz, A. and Voss, M. and Lawrie, S. M. and Mishara, A. and Bauer, M. and Gallinat, J{\"u}rgen and Juckel, G. and Lang, U. and Rapp, Michael A. and Falkai, P. and Strik, W. and Krystal, J. and Abi-Dargham, A. and Galderisi, S.},
  title     = {Shall we really say goodbye to first rank symptoms?},
  series = {European psychiatry : the journal of the Association of European Psychiatrists},
  volume    = {37},
  journal   = {European psychiatry : the journal of the Association of European Psychiatrists},
  publisher = {Elsevier},
  address   = {Paris},
  issn      = {0924-9338},
  doi       = {10.1016/j.eurpsy.2016.04.010},
  pages     = {8 -- 13},
  year      = {2016},
  abstract  = {Background: First rank symptoms (FRS) of schizophrenia have been used for decades for diagnostic purposes. In the new version of the DSM-5, the American Psychiatric Association (APA) has abolished any further reference to FRS of schizophrenia and treats them like any other "criterion A' symptom (e.g. any kind of hallucination or delusion) with regard to their diagnostic implication. The ICD-10 is currently under revision and may follow suit. In this review, we discuss central points of criticism that are directed against the continuous use of first rank symptoms (FRS) to diagnose schizophrenia.},
  language  = {en}
}
@misc{LichtDupontNivetPullenetal.2016,
  author    = {Licht, Alexis and Dupont-Nivet, Guillaume and Pullen, Alex and Kapp, Paul and Abels, Hemmo A. and Lai, Zulong and Guo, ZhaoJie and Abell, Jordan and Giesler, Dominique},
  title     = {Resilience of the Asian atmospheric circulation shown by paleogene dust provenance},
  series = {Postprints der Universit{\"a}t Potsdam : Mathematisch-Naturwissenschaftliche Reihe},
  journal   = {Postprints der Universit{\"a}t Potsdam : Mathematisch-Naturwissenschaftliche Reihe},
  number    = {1114},
  issn      = {1866-8372},
  doi       = {10.25932/publishup-43638},
  url       = {http://nbn-resolving.de/urn:nbn:de:kobv:517-opus4-436381},
  pages     = {8},
  year      = {2016},
  abstract  = {The onset of modern central Asian atmospheric circulation is traditionally linked to the interplay of surface uplift of the Mongolian and Tibetan-Himalayan orogens, retreat of the Paratethys sea from central Asia and Cenozoic global cooling. Although the role of these players has not yet been unravelled, the vast dust deposits of central China support the presence of arid conditions and modern atmospheric pathways for the last 25 million years (Myr). Here, we present provenance data from older (42-33 Myr) dust deposits, at a time when the Tibetan Plateau was less developed, the Paratethys sea still present in central Asia and atmospheric pCO(2) much higher. Our results show that dust sources and near-surface atmospheric circulation have changed little since at least 42 Myr. Our findings indicate that the locus of central Asian high pressures and concurrent aridity is a resilient feature only modulated by mountain building, global cooling and sea retreat.},
  language  = {en}
}
@article{AbdallaAbramowskiAharonianetal.2016,
  author    = {Abdalla, Hassan E. and Abramowski, Attila and Aharonian, Felix A. and Benkhali, Faical Ait and Akhperjanian, A. G. and Andersson, T. and Ang{\"u}ner, Ekrem Oǧuzhan and Arrieta, M. and Aubert, Pierre and Backes, Michael and Balzer, Arnim and Barnard, Michelle and Becherini, Yvonne and Tjus, J. Becker and Berge, David and Bernhard, Sabrina and Bernl{\"o}hr, K. and Birsin, E. and Blackwell, R. and Boettcher, Markus and Boisson, Catherine and Bolmont, J. and Bordas, Pol and Bregeon, Johan and Brun, Francois and Brun, Pierre and Bryan, Mark and Bulik, Tomasz and Capasso, M. and Carr, John and Casanova, Sabrina and Chakraborty, N. and Chalme-Calvet, R. and Chaves, Ryan C. G. and Chen, Andrew and Chevalier, J. and Chretien, M. and Colafrancesco, Sergio and Cologna, Gabriele and Condon, B. and Conrad, Jan and Couturier, C. and Cui, Y. and Davids, I. D. and Degrange, B. and Deil, C. and Devin, J. and de Wilt, P. and Djannati-Ataie, A. and Domainko, W. and Donath, A. and Dubus, G. and Dutson, K. and Dyks, J. and Dyrda, M. and Edwards, T. and Egberts, Kathrin and Eger, P. and Ernenwein, J. -P. and Eschbach, S. and Farnier, C. and Fegan, S. and Fernandes, M. V. and Fiasson, A. and Fontaine, G. and Foerster, A. and Funk, S. and Fuessling, M. and Gabici, S. and Gajdus, M. and Gallant, Y. A. and Garrigoux, T. and Giavitto, G. and Giebels, B. and Glicenstein, J. F. and Gottschall, D. and Goyal, A. and Grondin, M. -H. and Grudzinska, M. and Hadasch, D. and Hahn, J. and Hawkes, J. and Heinzelmann, G. and Henri, G. and Hermann, G. and Hervet, O. and Hillert, A. and Hinton, James Anthony and Hofmann, W. and Hoischen, Clemens and Holler, M. and Horns, D. and Ivascenko, A. and Jacholkowska, A. and Jamrozy, M. and Janiak, M. and Jankowsky, D. and Jankowsky, F. and Jingo, M. and Jogler, T. and Jouvin, L. and Jung-Richardt, I. and Kastendieck, M. A. and Katarzynski, K. and Katz, U. and Kerszberg, D. and Khelifi, B. and Kieffer, M. and King, J. and Klepser, S. and Klochkov, D. and Kluzniak, W. and Kolitzus, D. and Komin, Nu. and Kosack, K. and Krakau, S. and Kraus, M. and Krayzel, F. and Krueger, P. P. and Laffon, H. and Lamanna, G. and Lau, J. and Lees, J. -P. and Lefaucheur, J. and Lefranc, V. and Lemiere, A. and Lemoine-Goumard, M. and Lenain, J. -P. and Leser, Eva and Liu, R. and Lohse, T. and Lorentz, M. and Lypova, I. and Marandon, V. and Marcowith, Alexandre and Mariaud, C. and Marx, R. and Maurin, G. and Maxted, N. and Mayer, Michael and Meintjes, P. J. and Meyer, M. and Mitchell, A. M. W. and Moderski, R. and Mohamed, M. and Mora, K. and Moulin, Emmanuel and Murach, T. and de Naurois, M. and Niederwanger, F. and Niemiec, J. and Oakes, L. and Odaka, H. and Ohm, S. and Ostrowski, M. and Oettl, S. and Oya, I. and Padovani, M. and Panter, M. and Parsons, R. D. and Arribas, M. Paz and Pekeur, N. W. and Pelletier, G. and Perennes, C. and Petrucci, P. -O. and Peyaud, B. and Pita, S. and Poon, H. and Prokhorov, D. and Prokoph, H. and Puehlhofer, G. and Punch, M. and Quirrenbach, A. and Raab, S. and Reimer, A. and Reimer, O. and Renaud, M. and Reyes, R. de los and Rieger, F. and Romoli, C. and Rosier-Lees, S. and Rowell, G. and Rudak, B. and Rulten, C. B. and Sahakian, V. and Salek, D. and Sanchez, David M. and Santangelo, Andrea and Sasaki, M. and Schlickeiser, R. and Schuessler, F. and Schulz, A. and Schwanke, U. and Schwemmer, S. and Settimo, M. and Seyffert, A. S. and Shafi, N. and Shilon, I. and Simoni, R. and Sol, H. and Spanier, F. and Spengler, G. and Spies, F. and Stawarz, L. and Steenkamp, R. and Stegmann, Christian and Stinzing, F. and Stycz, K. and Sushch, Iurii and Tavernet, J. -P. and Tavernier, T. and Taylor, A. M. and Terrier, R. and Tibaldo, L. and Tluczykont, M. and Trichard, C. and Tuffs, R. and van der Walt, J. and van Eldik, C. and van Soelen, B. and Vasileiadis, G. and Veh, J. and Venter, C. and Viana, A. and Vincent, P. and Vink, J. and Voisin, F. and Voelk, H. J. and Vuillaume, T. and Wadiasingh, Z. and Wagner, S. J. and Wagner, P. and Wagner, R. M. and White, R. and Wierzcholska, A. and Willmann, P. and Woernlein, A. and Wouters, D. and Yang, R. and Zabalza, V. and Zaborov, D. and Zacharias, M. and Zdziarski, A. A. and Zech, Alraune and Zefi, F. and Ziegler, A. and Zywucka, N.},
  title     = {HESS Limits on Linelike Dark Matter Signatures in the 100 GeV to 2 TeV Energy Range Close to the Galactic Center},
  series = {Physical review letters},
  volume    = {117},
  journal   = {Physical review letters},
  publisher = {American Physical Society},
  address   = {College Park},
  organization    = {HESS Collaboration},
  issn      = {0031-9007},
  doi       = {10.1103/PhysRevLett.117.151302},
  pages     = {7},
  year      = {2016},
  abstract  = {A search for dark matter linelike signals iss performed in the vicinity of the Galactic Center by the H.E.S.S. experiment on observational data taken in 2014. An unbinned likelihood analysis iss developed to improve the sensitivity to linelike signals. The upgraded analysis along with newer data extend the energy coverage of the previous measurement down to 100 GeV. The 18 h of data collected with the H.E.S.S. array allow one to rule out at 95\% C.L. the presence of a 130 GeV line (at l = -1.5 degrees, b = 0 degrees and for a dark matter profile centered at this location) previously reported in Fermi-LAT data. This new analysis overlaps significantly in energy with previous Fermi-LAT and H.E.S.S. results. No significant excess associated with dark matter annihilations was found in the energy range of 100 GeV to 2 TeV and upper limits on the gamma-ray flux and the velocity weighted annihilation cross section are derived adopting an Einasto dark matter halo profile. Expected limits for present and future large statistics H.E.S.S. observations are also given.},
  language  = {en}
}
@article{AbramowskiAharonianBenkhalietal.2016,
  author    = {Abramowski, Attila and Aharonian, Felix A. and Benkhali, Faical Ait and Akhperjanian, A. G. and Ang{\"u}ner, Ekrem Oǧuzhan and Backes, Michael and Balzer, Arnim and Becherini, Yvonne and Tjus, J. Becker and Berge, David and Bernhard, Sabrina and Bernl{\"o}hr, K. and Birsin, E. and Blackwell, R. and Boettcher, Markus and Boisson, Catherine and Bolmont, J. and Bordas, Pol and Bregeon, Johan and Brun, Francois and Brun, Pierre and Bryan, Mark and Bulik, Tomasz and Carr, John and Casanova, Sabrina and Chakraborty, N. and Chalme-Calvet, R. and Chaves, Ryan C. G. and Chen, Andrew and Chretien, M. and Colafrancesco, Sergio and Cologna, Gabriele and Conrad, Jan and Couturier, C. and Cui, Y. and Davids, I. D. and Degrange, B. and Deil, C. and deWilt, P. and Djannati-Ata, A. and Domainko, W. and Donath, A. and Dubus, G. and Dutson, K. and Dyks, J. and Dyrda, M. and Edwards, T. and Egberts, Kathrin and Eger, P. and Ernenwein, J-P. and Espigat, P. and Farnier, C. and Fegan, S. and Feinstein, F. and Fernandes, M. V. and Fernandez, D. and Fiasson, A. and Fontaine, G. and Foerster, A. and Fuessling, M. and Gabici, S. and Gajdus, M. and Gallant, Y. A. and Garrigoux, T. and Giavitto, G. and Giebels, B. and Glicenstein, J. F. and Gottschall, D. and Goyal, A. and Grondin, M-H. and Grudzinska, M. and Hadasch, D. and Haeffner, S. and Hahn, J. and Hawkes, J. and Heinzelmann, G. and Henri, G. and Hermann, G. and Hervet, O. and Hillert, A. and Hinton, James Anthony and Hofmann, W. and Hofverberg, P. and Hoischen, Clemens and Holler, M. and Horns, D. and Ivascenko, A. and Jacholkowska, A. and Jamrozy, M. and Janiak, M. and Jankowsky, F. and Jung-Richardt, I. and Kastendieck, M. A. and Katarzynski, K. and Katz, U. and Kerszberg, D. and Khelifi, B. and Kieffer, M. and Klepser, S. and Klochkov, D. and Kluzniak, W. and Kolitzus, D. and Komin, Nu. and Kosack, K. and Krakau, S. and Krayzel, F. and Krueger, P. P. and Laffon, H. and Lamanna, G. and Lau, J. and Lefaucheur, J. and Lefranc, V. and Lemiere, A. and Lemoine-Goumard, M. and Lenain, J-P. and Lohse, T. and Lopatin, A. and Lu, C-C. and Lui, R. and Marandon, V. and Marcowith, Alexandre and Mariaud, C. and Marx, R. and Maurin, G. and Maxted, N. and Mayer, M. and Meintjes, P. J. and Menzler, U. and Meyer, M. and Mitchell, A. M. W. and Moderski, R. and Mohamed, M. and Mora, K. and Moulin, Emmanuel and Murach, T. and de Naurois, M. and Niemiec, J. and Oakes, L. and Odaka, H. and Oettl, S. and Ohm, S. and Opitz, B. and Ostrowski, M. and Oya, I. and Panter, M. and Parsons, R. D. and Arribas, M. Paz and Pekeur, N. W. and Pelletier, G. and Petrucci, P-O. and Peyaud, B. and Pita, S. and Poon, H. and Prokoph, H. and Puehlhofer, G. and Punch, M. and Quirrenbach, A. and Raab, S. and Reichardt, I. and Reimer, A. and Reimer, O. and Renaud, M. and de los Reyes, R. and Rieger, F. and Romoli, C. and Rosier-Lees, S. and Rowell, G. and Rudak, B. and Rulten, C. B. and Sahakian, V. and Salek, D. and Sanchez, David M. and Santangelo, Andrea and Sasaki, M. and Schlickeiser, R. and Schuessler, F. and Schulz, A. and Schwanke, U. and Schwemmer, S. and Seyffert, A. S. and Simoni, R. and Sol, H. and Spanier, F. and Spengler, G. and Spies, F. and Stawarz, L. and Steenkamp, R. and Stegmann, Christian and Stinzing, F. and Stycz, K. and Sushch, Iurii and Tavernet, J-P. and Tavernier, T. and Taylor, A. M. and Terrier, R. and Tluczykont, M. and Trichard, C. and Tuffs, R. and Valerius, K. and van der Walt, J. and van Eldik, C. and van Soelen, B. and Vasileiadis, G. and Veh, J. and Venter, C. and Viana, A. and Vincent, P. and Vink, J. and Voisin, F. and Voelk, H. J. and Vuillaume, T. and Wagner, S. J. and Wagner, P. and Wagner, R. M. and Weidinger, M. and Weitzel, Q. and White, R. and Wierzcholska, A. and Willmann, P. and Woernlein, A. and Wouters, D. and Yang, R. and Zabalza, V. and Zaborov, D. and Zacharias, M. and Zdziarski, A. A. and Zech, Alraune and Zefi, F. and Zywucka, N.},
  title     = {Acceleration of petaelectronvolt protons in the Galactic Centre},
  series = {Nature : the international weekly journal of science},
  volume    = {531},
  journal   = {Nature : the international weekly journal of science},
  publisher = {Nature Publ. Group},
  address   = {London},
  organization    = {HESS Collaboration},
  issn      = {0028-0836},
  doi       = {10.1038/nature17147},
  pages     = {476 -- +},
  year      = {2016},
  abstract  = {Galactic cosmic rays reach energies of at least a few petaelectronvolts (of the order of 1015 electronvolts). This implies that our Galaxy contains petaelectronvolt accelerators ('PeVatrons'), but all proposed models of Galactic cosmic-ray accelerators encounter difficulties at exactly these energies. Dozens of Galactic accelerators capable of accelerating particles to energies of tens of teraelectronvolts (of the order of 1013 electronvolts) were inferred from recent \&\#947;-ray observations3. However, none of the currently known accelerators—not even the handful of shell-type supernova remnants commonly believed to supply most Galactic cosmic rays—has shown the characteristic tracers of petaelectronvolt particles, namely, power-law spectra of \&\#947;-rays extending without a cut-off or a spectral break to tens of teraelectronvolts4. Here we report deep \&\#947;-ray observations with arcminute angular resolution of the region surrounding the Galactic Centre, which show the expected tracer of the presence of petaelectronvolt protons within the central 10 parsecs of the Galaxy. We propose that the supermassive black hole Sagittarius A* is linked to this PeVatron. Sagittarius A* went through active phases in the past, as demonstrated by X-ray outbursts5and an outflow from the Galactic Centre6. Although its current rate of particle acceleration is not sufficient to provide a substantial contribution to Galactic cosmic rays, Sagittarius A* could have plausibly been more active over the last 106-107 years, and therefore should be considered as a viable alternative to supernova remnants as a source of petaelectronvolt Galactic cosmic rays.},
  language  = {en}
}
@article{BougeoisdeRafelisReichartetal.2016,
  author    = {Bougeois, Laurie and de Rafelis, Marc and Reichart, Gert-Jan and de Nooijer, Lennart J. and Dupont-Nivet, Guillaume},
  title     = {Mg/Ca in fossil oyster shells as palaeotemperature proxy, an example from the Palaeogene of Central Asia},
  series = {Palaeogeography, palaeoclimatology, palaeoecology : an international journal for the geo-sciences},
  volume    = {441},
  journal   = {Palaeogeography, palaeoclimatology, palaeoecology : an international journal for the geo-sciences},
  publisher = {Elsevier},
  address   = {Amsterdam},
  issn      = {0031-0182},
  doi       = {10.1016/j.palaeo.2015.09.052},
  pages     = {611 -- 626},
  year      = {2016},
  abstract  = {Fossil oyster shells are well-suited to provide palaeotemperature proxies from geologic to seasonal timescales due to their ubiquitous occurrence from Triassic to Quaternary sediments, the seasonal nature of their shell growth and their relative strong resistance to post-mortem alteration. However, the common use to translate calcitic oxygen isotopes into palaeotemperatures is challenged by uncertainties in accounting for past seawater delta O-18, especially in shallow coastal environment where oysters calcify. In principle, the Mg/Ca ratio in oyster shells can provide an alternative palaeothermometer. Several studies provided temperature calibrations for this potential proxy based on modem species, nevertheless their application to palaeo-studies remains hitherto unexplored. Here, we show that past temperature variability in seawater can be obtained from Mg/Ca analyses from selected fossil oyster species and specimens. High-resolution Mg/Ca profiles, combined with delta O-18, were obtained along 41 fossil oyster shells of seven different species from the Palaeogene Proto-Paratethys sea (Central Asia) found in similar as well as different depositional age and environments providing comparison. Suitable Mg/Ca profiles, defined by continuous cyclicity and reproducibility within one shell, are found to be consistent for specimens of the same species but differ systematically between species, implying a dominant species-specific effect on the Mg/Ca signal. Two species studied here (Ostrea (Turkostrea) strictiplicata and Sokolowia buhsii) provide an excellent proxy for palaeoclimate reconstruction from China to Europe in Palaeogene marine sediments. More generally, the protocol developed here can be applied to identify other fossil oyster species suitable for palaeoclimate reconstructions. (C) 2015 Elsevier B.V. All rights reserved.},
  language  = {en}
}
@article{KonradJacobRappetal.2016,
  author    = {Konrad, Marcel and Jacob, Louis and Rapp, Michael A. and Kostev, Karel},
  title     = {Treatment of depression in patients with cardiovascular diseases by German psychiatrists},
  series = {International journal of clinical pharmacology and therapeutics},
  volume    = {54},
  journal   = {International journal of clinical pharmacology and therapeutics},
  publisher = {Dustri-Verlag Dr. Karl Feistle},
  address   = {Deisenhofen-M{\~A}¼nchen},
  issn      = {0946-1965},
  doi       = {10.5414/CP202591},
  pages     = {557 -- 563},
  year      = {2016},
  abstract  = {Objective: To estimate the prevalence and the type of antidepressant medication prescribed by German psychiatrists to patients with depression and cardiovascular diseases (CVD). Methods: This study was a retrospective database analysis in Germany using the Disease Analyzer Database (IMS Health, Germany). The study population included 2,288 CVD patients between 40 and 90 years of age from 175 psychiatric practices. The observation period was between 2004 and 2013. Follow-up lasted up to 12 months and ended in April 2015. Also included were 2,288 non-CVD controls matched (1 : 1) to CVD cases on the basis of age, gender, health insurance coverage, depression severity, and diagnosing physician. Results: Mean age was 68.6 years. 46.2\% of patients were men, and 5.9\% had private health insurance coverage. Mild, moderate, or severe depression was present in 18.7\%, 60.7\%, and 20.6\% of patients, respectively. Most patients had treatment within a year, many of them immediately after depression diagnosis. Patients with moderate and severe depression were more likely to receive treatment than patients with mild depression. There was no difference between CVD and non-CVD in the proportion of patients treated. Nonetheless, CVD patients received selective serotonin reuptake inhibitors / serotonin-noradrenaline reuptake inhibitors (SSRIs/SNRIs) significantly more frequently. Conversely, patients without CVD were more often treated with TCA. Conclusion: There was no association between CVD and the initiation of depression treatment. Furthermore, CVD patients received SSRIs/SNRIs more frequently.},
  language  = {en}
}